Optimizing transfection of primary human umbilical vein endothelial cells using commercially available chemical transfection reagents

Journal of Biomolecular Techniques

Volumn 21, Issue 2, 2010, Pages 66-72

  Hunt, Michelle A ^a   Currie, Margaret J ^a   Robinson, Bridget A ^a   Dachs, Gabi U ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cytotoxicity; HUVEC

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; LIPOFECTAMINE; REAGENT;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; UMBILICAL VEIN;

CELL SURVIVAL; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HUMANS; INDICATORS AND REAGENTS; REAGENT KITS, DIAGNOSTIC; TRANSFECTION; UMBILICAL VEINS;

EID: 77955652412     PISSN: 15240215     EISSN: 19434731     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Colombo MG, Citti L, Basta G, De Caterina R, Biagini A, Rainaldi G. Differential ability of human endothelial cells to internalize and express exogenous DNA. Cardiovasc Drugs Ther 2001;15:25-29.
2. van Beijnum JR, van der Linden E, Griffioen AW. Angiogenic profiling and comparison of immortalized endothelial cells for functional genomics. Exp Cell Res 2008;314:264-272.
3. Nathwani AC, Gale KM, Pemberton KD, Crossman DC, Tuddenham EG, McVey JH. Efficient gene transfer into human umbilical vein endothelial cells allows functional analysis of the human tissue factor gene promoter. Br J Haematol 1994;88:122-128.
4. Jin Y, An X, Ye Z, Cully B, Wu J, Li J. RGS5, a hypoxia-inducible apoptotic stimulator in endothelial cells. J Biol Chem 2009;284:23436-23443.
5. Yang WY, Huang ZH, Lin LJ, et al. Kinase domain insert containing receptor promoter controlled suicide gene system selectively kills human umbilical vein endothelial cells. World J Gastroenterol 2006;12:5331-5335.
6. Kim TW, Kim HJ, Lee C, et al. Identification of replicative senescence-associated genes in human umbilical vein endothelial cells by an annealing control primer system. Exp Gerontol 2008;43:286-295.
7. Fife K, Bower M, Cooper RG, et al. Endothelial cell transfection with cationic liposomes and herpes simplex-thymidine kinase mediated killing. Gene Ther 1998;5:614-620.
8. Ojeifo JO, Su N, Ryan US, Verma UN, Mazumder A, Zwiebel JA. Towards endothelial-cell-directed cancer immunotherapy: in vitro expression of human recombinant cytokine genes by human and mouse primary endothelial cells. Cytokines Mol Ther 1996;2:89-101.
9. Azzam T, Domb AJ. Current developments in gene transfection agents. Curr Drug Deliv 2004;1:165-193.
10. Greco O, Scott SD, Marples B, Dachs GU. Cancer gene therapy: "delivery, delivery, delivery". Front Biosci 2002;7:d1516-d1524.
11. Kawakami S, Higuchi Y, Hashida M. Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide. J Pharm Sci 2008;97:726-745.
12. Villemejane J, Mir LM. Physical methods of nucleic acid transfer: general concepts and applications. Br J Pharmacol 2009;157:207-219.
13. Work LM, Ritchie N, Nicklin SA, Reynolds PN, Baker AH. Dual targeting of gene delivery by genetic modification of adenovirus serotype 5 fibers and cell-selective transcriptional control. Gene Ther 2004;11:1296-1300.
14. Glasgow JN, Bauerschmitz GJ, Curiel DT, Hemminki A. Transductional and transcriptional targeting of adenovirus for clinical applications. Curr Gene Ther 2004;4:1-14.
15. Kreppel F, Kochanek S. Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide. Mol Ther 2008;16:16-29.
16. Manilla P, Rebello T, Afable C, et al. Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther 2005;16:17-25.
17. Raty JK, Lesch HP, Wirth T, Yla-Herttuala S. Improving safety of gene therapy. Curr Drug Saf 2008;3:46-53.
18. Douglas KL. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection. Biotechnol Prog 2008;24:871-883.
19. Eliyahu H, Barenholz Y, Domb AJ. Polymers for DNA delivery. Molecules 2005;10:34-64.
20. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-2756.
21. Kovala AT, Harvey KA, McGlynn P, Boguslawski G, Garcia JG, English D. High-efficiency transient transfection of endothelial cells for functional analysis. FASEB J 2000;14:2486-2494.
22. Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit JP. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008;29:3477-3496.
23. Vijayanathan V, Thomas T, Thomas TJ. DNA nanoparticles and development of DNA delivery vehicles for gene therapy. Biochemistry 2002;41:14085-14094.
24. Ewert KK, Ahmad A, Bouxsein NF, Evans HM, Safinya CR. Non-viral gene delivery with cationic liposome-DNA complexes. Methods Mol Biol 2008;433:159-175.
25. Li S, Tan Y, Viroonchatapan E, Pitt BR, Huang L. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am J Physiol Lung Cell Mol Physiol 2000;278:L504-L511.
26. Muller K, Nahde T, Fahr A, Muller R, Brusselbach S. Highly efficient transduction of endothelial cells by targeted artificial virus-like particles. Cancer Gene Ther 2001;8:107-117.
27. Brunner S, Furtbauer E, Sauer T, Kursa M, Wagner E. Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol Ther 2002;5:80-86.
28. Georgatos SD, Pyrpasopoulou A, Theodoropoulos PA. Nuclear envelope breakdown in mammalian cells involves stepwise lamina disassembly and microtubule-drive deformation of the nuclear membrane. J Cell Sci 1997;110:2129-2140. (Pubitemid 27440436)
29. Zhi D, Zhang S, Wang B, Zhao Y, Yang B, Yu S. Transfection efficiency of cationic lipids with different hydrophobic domains in gene delivery. Bioconjug Chem 2010;21:563-577.
30. Aramaki Y, Takano S, Tsuchiya S. Cationic liposomes induce macrophage apoptosis through mitochondrial pathway. Arch Biochem Biophys 2001;392:245-250. (Pubitemid 32757035)
31. Teifel M, Heine LT, Milbredt S, Friedl P. Optimization of transfection of human endothelial cells. Endothelium 1997;5:21-35.
32. Uchida E, Mizuguchi H, Ishii-Watabe A, Hayakawa T. Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells. Biol Pharm Bull 2002;25:891-897.
33. Cook-Johnson RJ, Demasi M, Cleland LG, Gamble JR, Saint DA, James MJ. Endothelial cell COX-2 expression and activity in hypoxia. Biochim Biophys Acta 2006;1761:1443-1449.
34. Colosimo A, Goncz KK, Holmes AR, et al. Transfer and expression of foreign genes in mammalian cells. Biotechniques 2000;29:314-318, 320-312, 324.
35. Glee PM, Cutler JE, Benson EE, Bargatze RF, Hazen KC. Inhibition of hydrophobic protein-mediated Candida albicans attachment to endothelial cells during physiologic shear flow. Infect Immun 2001;69:2815-2820.
36. Strebel A, Harr T, Bachmann F, Wernli M, Erb P. Green fluorescent protein as a novel tool to measure apoptosis and necrosis. Cytometry 2001;43:126-133.
37. Welsh S, Kay SA. Reporter gene expression for monitoring gene transfer. Curr Opin Biotechnol 1997;8:617-622.
38. Guo B, Pearce AG, Traulsen KE, Rintala AC, Lee H. Fluorescence produced by transfection reagents can be confused with green fluorescent proteins in mammalian cells. Biotechniques 2001;31:314-316, 318, 320-311.